BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16873801)

  • 1. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans.
    Meyer C; Pimenta W; Woerle HJ; Van Haeften T; Szoke E; Mitrakou A; Gerich J
    Diabetes Care; 2006 Aug; 29(8):1909-14. PubMed ID: 16873801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?
    Piché ME; Després JP; Pascot A; Nadeau A; Tremblay A; Weisnagel SJ; Bergeron J; Lemieux S
    Diabet Med; 2004 Jul; 21(7):730-7. PubMed ID: 15209766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The distributive characteristics of impaired glucose metabolism subcategories in Chinese adult population].
    Yang ZJ; Yang WY; Li GW;
    Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(24):2128-31. PubMed ID: 14720420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.
    Pannacciulli N; De Mitrio V; Marino R; Giorgino R; De Pergola G
    Obes Res; 2002 Aug; 10(8):717-25. PubMed ID: 12181379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic beta-cell function and insulin sensitivity in japanese subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes mellitus.
    Kanauchi M; Nakajima M; Saito Y; Kanauchi K
    Metabolism; 2003 Apr; 52(4):476-81. PubMed ID: 12701062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.
    Weyer C; Bogardus C; Pratley RE
    Diabetes; 1999 Nov; 48(11):2197-203. PubMed ID: 10535454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
    Amoah AG; Schuster DP; Gaillard T; Osei K
    Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents.
    Gungor N; Saad R; Janosky J; Arslanian S
    J Pediatr; 2004 Jan; 144(1):47-55. PubMed ID: 14722518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
    Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
    Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of simple indices of insulin sensitivity using the euglycemic hyperinsulinemic clamp technique.
    Straczkowski M; Stepień A; Kowalska I; Kinalska I
    Med Sci Monit; 2004 Aug; 10(8):CR480-4. PubMed ID: 15277999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study.
    Tripathy D; Carlsson M; Almgren P; Isomaa B; Taskinen MR; Tuomi T; Groop LC
    Diabetes; 2000 Jun; 49(6):975-80. PubMed ID: 10866050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lowering postprandial hyperglycemia on insulin secretion in older people with impaired glucose tolerance.
    Chang AM; Smith MJ; Bloem CJ; Galecki AT; Halter JB
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E906-11. PubMed ID: 15213063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal and dynamic proinsulin-insulin relationship to assess beta-cell function during OGTT in metabolic disorders.
    Tura A; Pacini G; Kautzky-Willer A; Ludvik B; Prager R; Thomaseth K
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E155-62. PubMed ID: 12670835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose intolerance is predicted by the high Fasting Insulin-to-Glucose ratio.
    Guerrero-Romero F; Rodríguez-Morán M
    Diabetes Metab; 2001 Apr; 27(2 Pt 1):117-21. PubMed ID: 11353876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose.
    Festa A; D'Agostino R; Hanley AJ; Karter AJ; Saad MF; Haffner SM
    Diabetes; 2004 Jun; 53(6):1549-55. PubMed ID: 15161760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose oral glyburide reduces glucose production rates in patients with impaired fasting glucose.
    Bavirti S; Tayek JA
    Metabolism; 2003 Apr; 52(4):407-12. PubMed ID: 12701050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance.
    Ferrara CM; Goldberg AP
    Diabetes Care; 2001 Feb; 24(2):245-9. PubMed ID: 11213873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disturbances in beta-cell function in impaired fasting glycemia.
    van Haeften TW; Pimenta W; Mitrakou A; Korytkowski M; Jenssen T; Yki-Jarvinen H; Gerich JE
    Diabetes; 2002 Feb; 51 Suppl 1():S265-70. PubMed ID: 11815491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin secretory dysfunction and insulin resistance in the pathogenesis of korean type 2 diabetes mellitus.
    Kim DJ; Lee MS; Kim KW; Lee MK
    Metabolism; 2001 May; 50(5):590-3. PubMed ID: 11319722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S.
    Jensen CC; Cnop M; Hull RL; Fujimoto WY; Kahn SE;
    Diabetes; 2002 Jul; 51(7):2170-8. PubMed ID: 12086947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.